Cargando…

Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial

INTRODUCTION: Aragvadhadi Taila (ART) is one of the herbomineral formulations mentioned in Chakradatta indicated in Shwitra (vitiligo). Modification of Taila form into gel form reduces the risk of contamination in view of arsenical contents (Manahshila, Haratala) assures precise dose administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Makwana, Sarika, Parekh, Dipali, Bedarkar, Prashant, Patgiri, Biswajyoti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893897/
https://www.ncbi.nlm.nih.gov/pubmed/36743274
http://dx.doi.org/10.4103/ayu.AYU_323_20
_version_ 1784881621941354496
author Makwana, Sarika
Parekh, Dipali
Bedarkar, Prashant
Patgiri, Biswajyoti
author_facet Makwana, Sarika
Parekh, Dipali
Bedarkar, Prashant
Patgiri, Biswajyoti
author_sort Makwana, Sarika
collection PubMed
description INTRODUCTION: Aragvadhadi Taila (ART) is one of the herbomineral formulations mentioned in Chakradatta indicated in Shwitra (vitiligo). Modification of Taila form into gel form reduces the risk of contamination in view of arsenical contents (Manahshila, Haratala) assures precise dose administration at desired site (by avoiding spreading). The gel is a comparatively acceptable dosage form than that of medicated oil. AIM: The aim of the study is to evaluate the comparative efficacy of Aragvadhadi formulation in Taila (ART: Aragvadhadi Taila) and gel (ARG: Aragvadhadi gel) dosage forms with the internal administration of Rasayana Churna in the management of Shwitra. MATERIALS AND METHODS: The study was a randomized open labeled, involving 66 patients of Shwitra that were randomly divided into two groups. Patients registered in group A (n = 34) were treated with local applications of ART and group B (n = 32) with ARG for 2 months. Rasayana Churna (3 g), along with the equal quantity of honey and Ghrita was given twice a day after the meal in both groups. Wilcoxon signed-rank test was applied to evaluate the effect of therapy in the individual group for subjective criteria like vitiligo area scoring index score, size and number of patches, Rukshata (dryness), Saparidaha (burning sensation), Bahalatva (thickening), Kandu (itching) while the comparison of results between the groups for the same by applying Coefficient of Variation (CV). RESULTS: Group B showed better and consistent results in all signs and symptoms except Rukshata, Saparidaha in terms of Coefficient of Variation. In both the groups, statistically highly significant improvement was found in signs and symptoms of Shwitra such as Saparidaha, Kandu, size of patches and number of patches; however, the difference between the groups was statistically insignificant. CONCLUSION: Both the forms (ART, ARG) of Aragvadhadi formulation along with Rasayana Churna were found as a safe and effective treatment in vitiligo with significant pigment regeneration capacity as topical use for application over 2 months.
format Online
Article
Text
id pubmed-9893897
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-98938972023-02-03 Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial Makwana, Sarika Parekh, Dipali Bedarkar, Prashant Patgiri, Biswajyoti Ayu Original Article INTRODUCTION: Aragvadhadi Taila (ART) is one of the herbomineral formulations mentioned in Chakradatta indicated in Shwitra (vitiligo). Modification of Taila form into gel form reduces the risk of contamination in view of arsenical contents (Manahshila, Haratala) assures precise dose administration at desired site (by avoiding spreading). The gel is a comparatively acceptable dosage form than that of medicated oil. AIM: The aim of the study is to evaluate the comparative efficacy of Aragvadhadi formulation in Taila (ART: Aragvadhadi Taila) and gel (ARG: Aragvadhadi gel) dosage forms with the internal administration of Rasayana Churna in the management of Shwitra. MATERIALS AND METHODS: The study was a randomized open labeled, involving 66 patients of Shwitra that were randomly divided into two groups. Patients registered in group A (n = 34) were treated with local applications of ART and group B (n = 32) with ARG for 2 months. Rasayana Churna (3 g), along with the equal quantity of honey and Ghrita was given twice a day after the meal in both groups. Wilcoxon signed-rank test was applied to evaluate the effect of therapy in the individual group for subjective criteria like vitiligo area scoring index score, size and number of patches, Rukshata (dryness), Saparidaha (burning sensation), Bahalatva (thickening), Kandu (itching) while the comparison of results between the groups for the same by applying Coefficient of Variation (CV). RESULTS: Group B showed better and consistent results in all signs and symptoms except Rukshata, Saparidaha in terms of Coefficient of Variation. In both the groups, statistically highly significant improvement was found in signs and symptoms of Shwitra such as Saparidaha, Kandu, size of patches and number of patches; however, the difference between the groups was statistically insignificant. CONCLUSION: Both the forms (ART, ARG) of Aragvadhadi formulation along with Rasayana Churna were found as a safe and effective treatment in vitiligo with significant pigment regeneration capacity as topical use for application over 2 months. Wolters Kluwer - Medknow 2021 2022-12-07 /pmc/articles/PMC9893897/ /pubmed/36743274 http://dx.doi.org/10.4103/ayu.AYU_323_20 Text en Copyright: © 2022 AYU (An International Quarterly Journal of Research in Ayurveda) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Makwana, Sarika
Parekh, Dipali
Bedarkar, Prashant
Patgiri, Biswajyoti
Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial
title Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial
title_full Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial
title_fullStr Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial
title_full_unstemmed Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial
title_short Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial
title_sort efficacy of external application of oil and gel dosage forms of aragvadhadi formulation in combination with rasayana churna in the management of shwitra (vitiligo) - an open-labeled comparative clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893897/
https://www.ncbi.nlm.nih.gov/pubmed/36743274
http://dx.doi.org/10.4103/ayu.AYU_323_20
work_keys_str_mv AT makwanasarika efficacyofexternalapplicationofoilandgeldosageformsofaragvadhadiformulationincombinationwithrasayanachurnainthemanagementofshwitravitiligoanopenlabeledcomparativeclinicaltrial
AT parekhdipali efficacyofexternalapplicationofoilandgeldosageformsofaragvadhadiformulationincombinationwithrasayanachurnainthemanagementofshwitravitiligoanopenlabeledcomparativeclinicaltrial
AT bedarkarprashant efficacyofexternalapplicationofoilandgeldosageformsofaragvadhadiformulationincombinationwithrasayanachurnainthemanagementofshwitravitiligoanopenlabeledcomparativeclinicaltrial
AT patgiribiswajyoti efficacyofexternalapplicationofoilandgeldosageformsofaragvadhadiformulationincombinationwithrasayanachurnainthemanagementofshwitravitiligoanopenlabeledcomparativeclinicaltrial